AP2011005755A0 - Treatment of inflammatory bowel diseases with mammal beta defensins. - Google Patents

Treatment of inflammatory bowel diseases with mammal beta defensins.

Info

Publication number: AP2011005755A0
Authority: AP; ARIPO
Prior art keywords: treatment; inflammatory bowel; bowel diseases; beta defensins; mammal beta
Prior art date: 2008-07-18

Application number

AP2011005755A

Other languages

English (en)

Inventor

Soeren Kjaerulff

Thomas Kruse

Tanja Maria Rosenkilde Kjaer

Original Assignee

Novozymes Adenium Biotech As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-07-18

Filing date

2009-07-17

Publication date

2011-06-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41530820&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2011005755(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-07-17 Application filed by Novozymes Adenium Biotech As filed Critical Novozymes Adenium Biotech As

2011-06-30 Publication of AP2011005755A0 publication Critical patent/AP2011005755A0/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Zoology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Marine Sciences & Fisheries (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Toxicology (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Communicable Diseases (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AP2011005755A 2008-07-18 2009-07-17 Treatment of inflammatory bowel diseases with mammal beta defensins. AP2011005755A0 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP08160761		2008-07-18
EP08162486		2008-08-15
EP08163614		2008-09-03
PCT/EP2009/059253 WO2010007166A2 (en)	2008-07-18	2009-07-17	Treatment of inflammatory bowel diseases with mammal beta defensins

Publications (1)

Publication Number	Publication Date
AP2011005755A0 true AP2011005755A0 (en)	2011-06-30

Family

ID=41530820

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AP2011005538A AP2011005538A0 (en)	2008-07-18	2009-07-17	Treatment of inflammatory bowel diseases with mammal beta defensins.
AP2011005755A AP2011005755A0 (en)	2008-07-18	2009-07-17	Treatment of inflammatory bowel diseases with mammal beta defensins.

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AP2011005538A AP2011005538A0 (en)	2008-07-18	2009-07-17	Treatment of inflammatory bowel diseases with mammal beta defensins.

Country Status (20)

Country	Link
US (4)	US8232242B2 (ko)
EP (2)	EP2399600A1 (ko)
JP (2)	JP2011528333A (ko)
KR (1)	KR20110092325A (ko)
CN (2)	CN102247591A (ko)
AP (2)	AP2011005538A0 (ko)
AR (2)	AR072032A1 (ko)
AU (1)	AU2009272681A1 (ko)
BR (2)	BRPI0924481A2 (ko)
CA (2)	CA2750727A1 (ko)
CL (1)	CL2011000099A1 (ko)
EA (2)	EA201100910A1 (ko)
IL (2)	IL210715A0 (ko)
MX (1)	MX2011000568A (ko)
NZ (2)	NZ590468A (ko)
PH (1)	PH12012501542A1 (ko)
SG (1)	SG172709A1 (ko)
TW (2)	TW201004640A (ko)
WO (1)	WO2010007166A2 (ko)
ZA (1)	ZA201100461B (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2399600A1 (en)	2008-07-18	2011-12-28	Novozymes Adenium Biotech A/S	Treatment of inflammatory bowel diseases with mammal beta defensins
CA2730666A1 (en) *	2008-07-18	2010-01-21	Novozymes Adenium Biotech A/S	Treatment of rheumatoid arthritis with mammal beta defensins
AR072524A1 (es) *	2008-07-18	2010-09-01	Novozymes As	Tratamiento de enfermedades inflamatorias con beta defensinas de mamiferos
KR101329774B1 (ko) *	2010-06-16	2013-11-15	주식회사 나이벡	항균 또는 항염증 활성을 가지는 펩타이드 및 이를 유효성분으로 함유하는 약제학적 조성물
NZ732118A (en)	2011-04-15	2018-11-30	Marine Polymer Tech Inc	Treatment of disease with poly-n-acetylglucosamine nanofibers
WO2013007596A2 (en)	2011-07-08	2013-01-17	Novozymes A/S	Oral treatment of inflammatory bowel disease
WO2013026794A1 (en)	2011-08-19	2013-02-28	Novozymes	Novel immunomodulatory peptide
US10257564B2 (en) *	2013-01-24	2019-04-09	Saturn Licensing Llc	Distributed non-real-time content
CN104628864B (zh) *	2013-11-14	2020-04-10	中国医学科学院医药生物技术研究所	一种抗肿瘤融合蛋白EL-defensin、其编码基因和用途
JP2019514908A (ja)	2016-04-29	2019-06-06	ディフェンシンセラピューティクスエーピーエス	肝臓、胆管および膵臓の障害の治療
CA3045079A1 (en)	2016-12-13	2018-06-21	Defensin Therapeutics Aps	Methods for treating inflammatory conditions of the lungs
CN111556759A (zh)	2017-11-10	2020-08-18	防御素治疗学公司	早产儿中的粘膜防御和肠道/肺功能的成熟化
MX2020005370A (es)	2017-11-24	2020-10-19	Defensin Therapeutics Aps	Prevencion y tratamiento de enfermedad de injerto contra hospedero con defensinas.
KR102244161B1 (ko) *	2018-08-31	2021-04-26	주식회사 나이벡	다중의 질환 바이오마커의 기능 및 발현을 억제하는 펩타이드의 신규한 용도
CN113684162B (zh) *	2021-06-03	2024-02-27	江南大学	一种表达小鼠防御素mBD14基因的重组植物乳杆菌及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5223409A (en)	1988-09-02	1993-06-29	Protein Engineering Corp.	Directed evolution of novel binding proteins
IL99552A0 (en)	1990-09-28	1992-08-18	Ixsys Inc	Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
DE4343591A1 (de)	1993-12-21	1995-06-22	Evotec Biosystems Gmbh	Verfahren zum evolutiven Design und Synthese funktionaler Polymere auf der Basis von Formenelementen und Formencodes
US5605793A (en)	1994-02-17	1997-02-25	Affymax Technologies N.V.	Methods for in vitro recombination
US6576755B1 (en) *	1997-09-10	2003-06-10	Zymogenetics, Inc.	Beta-defensins
DE19957043A1 (de) *	1999-11-26	2001-06-07	Forssmann Wolf Georg	Neue Defensine
US7338936B2 (en) *	2000-11-28	2008-03-04	House Ear Institute	Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
US20080194481A1 (en) *	2001-12-21	2008-08-14	Human Genome Sciences, Inc.	Albumin Fusion Proteins
FR2841556B1 (fr)	2002-07-01	2007-07-20	Centre Nat Rech Scient	Peptides ayant des proprietes antimicrobiennes et les compositions les contenant notamment pour la conservation des aliments
CA2508273A1 (en)	2002-12-19	2004-07-08	Yitzchak Hillman	Disease treatment via antimicrobial peptide inhibitors
US20070207209A1 (en)	2004-08-27	2007-09-06	Murphy Christopher J	Trophic factor combinations for nervous system treatment
GB0514482D0 (en) *	2005-07-14	2005-08-17	Ares Trading Sa	Protein
WO2007081486A2 (en) *	2005-12-15	2007-07-19	Ventria Bioscience	Oral administration of defensins to treat intestinal diseases
WO2007087557A2 (en)	2006-01-24	2007-08-02	University Of Maryland Biotechnology Institute	Surface-layer protein coated microspheres and uses thereof
CA2699163A1 (en) *	2007-09-11	2009-04-16	Mondobiotech Laboratories Ag	Use of a peptide as a therapeutic agent
AR072524A1 (es)	2008-07-18	2010-09-01	Novozymes As	Tratamiento de enfermedades inflamatorias con beta defensinas de mamiferos
CA2730666A1 (en)	2008-07-18	2010-01-21	Novozymes Adenium Biotech A/S	Treatment of rheumatoid arthritis with mammal beta defensins
EP2399600A1 (en)	2008-07-18	2011-12-28	Novozymes Adenium Biotech A/S	Treatment of inflammatory bowel diseases with mammal beta defensins
WO2013007596A2 (en)	2011-07-08	2013-01-17	Novozymes A/S	Oral treatment of inflammatory bowel disease
WO2013026794A1 (en)	2011-08-19	2013-02-28	Novozymes	Novel immunomodulatory peptide

2009
- 2009-07-17 EP EP11182338A patent/EP2399600A1/en not_active Withdrawn
- 2009-07-17 EA EA201100910A patent/EA201100910A1/ru unknown
- 2009-07-17 CA CA2750727A patent/CA2750727A1/en not_active Abandoned
- 2009-07-17 NZ NZ590468A patent/NZ590468A/en not_active IP Right Cessation
- 2009-07-17 BR BRPI0924481-6A patent/BRPI0924481A2/pt not_active IP Right Cessation
- 2009-07-17 CA CA2730789A patent/CA2730789A1/en not_active Abandoned
- 2009-07-17 SG SG2011043452A patent/SG172709A1/en unknown
- 2009-07-17 NZ NZ593653A patent/NZ593653A/xx not_active IP Right Cessation
- 2009-07-17 EA EA201170219A patent/EA201170219A1/ru unknown
- 2009-07-17 US US12/504,909 patent/US8232242B2/en active Active
- 2009-07-17 JP JP2011517955A patent/JP2011528333A/ja active Pending
- 2009-07-17 CN CN201110163184XA patent/CN102247591A/zh active Pending
- 2009-07-17 AR ARP090102741A patent/AR072032A1/es not_active Application Discontinuation
- 2009-07-17 AP AP2011005538A patent/AP2011005538A0/xx unknown
- 2009-07-17 EP EP09780791A patent/EP2320930A2/en not_active Withdrawn
- 2009-07-17 AP AP2011005755A patent/AP2011005755A0/xx unknown
- 2009-07-17 CN CN2009801363438A patent/CN102159233A/zh active Pending
- 2009-07-17 BR BRPI0915973-8A patent/BRPI0915973A2/pt not_active IP Right Cessation
- 2009-07-17 KR KR1020117014574A patent/KR20110092325A/ko not_active Application Discontinuation
- 2009-07-17 WO PCT/EP2009/059253 patent/WO2010007166A2/en active Application Filing
- 2009-07-17 MX MX2011000568A patent/MX2011000568A/es not_active Application Discontinuation
- 2009-07-17 AU AU2009272681A patent/AU2009272681A1/en not_active Abandoned
- 2009-07-20 TW TW098124402A patent/TW201004640A/zh unknown
- 2009-07-20 TW TW100128455A patent/TW201138810A/zh unknown
2011
- 2011-01-17 CL CL2011000099A patent/CL2011000099A1/es unknown
- 2011-01-18 IL IL210715A patent/IL210715A0/en unknown
- 2011-01-18 ZA ZA2011/00461A patent/ZA201100461B/en unknown
- 2011-06-13 US US13/158,638 patent/US8802621B2/en active Active
- 2011-06-16 AR ARP110102093A patent/AR081948A2/es not_active Application Discontinuation
- 2011-06-21 IL IL213680A patent/IL213680A0/en unknown
- 2011-06-29 JP JP2011144522A patent/JP2011225596A/ja active Pending
2012
- 2012-07-09 US US13/544,253 patent/US20120309678A1/en not_active Abandoned
- 2012-07-27 PH PH12012501542A patent/PH12012501542A1/en unknown
2014
- 2014-01-30 US US14/168,849 patent/US9279010B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
BRPI0915973A2 (pt)	2013-05-07
AR081948A2 (es)	2012-10-31
JP2011528333A (ja)	2011-11-17
US20110251139A1 (en)	2011-10-13
ZA201100461B (en)	2014-03-26
KR20110092325A (ko)	2011-08-17
AR072032A1 (es)	2010-07-28
IL210715A0 (en)	2011-03-31
EP2399600A1 (en)	2011-12-28
EA201100910A1 (ru)	2012-05-30
US8232242B2 (en)	2012-07-31
JP2011225596A (ja)	2011-11-10
TW201004640A (en)	2010-02-01
CA2750727A1 (en)	2010-01-21
CL2011000099A1 (es)	2011-10-07
CA2730789A1 (en)	2010-01-21
IL213680A0 (en)	2011-07-31
SG172709A1 (en)	2011-07-28
CN102247591A (zh)	2011-11-23
US20120309678A1 (en)	2012-12-06
US20100016230A1 (en)	2010-01-21
CN102159233A (zh)	2011-08-17
US8802621B2 (en)	2014-08-12
PH12012501542A1 (en)	2015-11-09
NZ593653A (en)	2012-09-28
BRPI0924481A2 (pt)	2015-08-11
WO2010007166A3 (en)	2010-06-03
EP2320930A2 (en)	2011-05-18
AP2011005538A0 (en)	2011-02-28
EA201170219A1 (ru)	2011-08-30
MX2011000568A (es)	2011-02-23
AU2009272681A1 (en)	2010-01-21
TW201138810A (en)	2011-11-16
NZ590468A (en)	2012-06-29
WO2010007166A2 (en)	2010-01-21
US9279010B2 (en)	2016-03-08
US20140135258A1 (en)	2014-05-15

Publication	Publication Date	Title
AP2011005538A0 (en)	2011-02-28	Treatment of inflammatory bowel diseases with mammal beta defensins.
AP2011005537A0 (en)	2011-02-28	Treatment of inflammatory diseases with mammal beta defensins.
GB2450974B (en)	2012-02-29	Treatment of inflammatory bowel disease with cannabinoids
IL200368A0 (en)	2010-04-29	Treatment of diseases characterized by inflammation
HK1131047A1 (en)	2010-01-15	Treatment of inflammatory diseases
ZA200707591B (en)	2009-08-26	Dihyrothienopyrimidines for the treatment of inflammatory diseases
ZA201009030B (en)	2012-03-28	Methods of treating inflammatory colon disease
ZA201100974B (en)	2012-10-31	Treatment of autoimmune and inflammatory disease
EP2289518A4 (en)	2012-04-11	THERAPEUTIC AGENT FOR INFLAMMATORY ABDOMINAL DISEASE
EP2107870A4 (en)	2012-05-09	IMPROVED IRRITANT-REDUCED WASH FOR THE TREATMENT OF INFLAMMATORY INTESTINAL DISEASE (IBD)
EP2403503A4 (en)	2012-10-10	METHOD FOR THE TREATMENT OF EYE IGNITIONS
GB0700972D0 (en)	2007-02-28	Treatment of inflammatory disease
IL210716A0 (en)	2011-03-31	Treatment of rheumatoid arthritis with mammal beta defensins
ZA200905364B (en)	2010-05-26	Treatment of diseases characterized by inflammation
IL255052A0 (en)	2017-12-31	Treatment of inflammatory bowel diseases by 6-mercaptopurine
GB0720976D0 (en)	2007-12-05	Treatment of inflammatory disease
HUE042736T2 (hu)	2019-07-29	Gyulladásos vagy autoimmun rendellenességek kezelésének irányítása HOM-1 kifejezés alkalmazásával
PT2328553T (pt)	2020-08-25	Corticosteroides para o tratamento de doenças inflamatórias do trato gastrointestinal
EP2416803A4 (en)	2012-12-26	NEW METHODS OF TREATING INFLAMMATORY DISEASES
HK1158954A1 (en)	2012-07-27	1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases
EP2296683A4 (en)	2012-03-07	METHOD FOR THE TREATMENT OF INFLAMMATORY ENDURANCE AND TREATMENT OF THEIR SYMPTOMS
UA99539C2 (ru)	2012-08-27	Лечение воспалительных заболеваний кишечника бета-дефензинами человека
GB0915348D0 (en)	2009-10-07	Efficient therapy for subjects with inflammatory bowel diseases
BR112012015012A2 (pt)	2019-09-24	tratamento para doença de intestino inflamatória
IL202502A (en)	2016-04-21	Cxcl11 for the treatment of inflammatory diseases